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Abstract
Purpose – The purpose of this paper is to describe the history of pharmacist involvement as vaccine
providers in the USA and discuss examples of growing interests in other parts of the world.
Design/methodology/approach – Literature searches were performed in PubMed as well as
pharmacy-related journals.
Findings – Pharmacists have been involved with the storage and management of vaccines for more than a
century. Based on the unmet needs in meeting national goals for vaccination rates among adults in the USA,
efforts led to training and recognizing pharmacists as vaccine providers which is now within the scope of
practice for a pharmacist in all US states and territories. Pharmacists complete a comprehensive training
program in vaccine sciences, regulatory considerations, as well as demonstration of skills in administering
vaccines. Over 300,000 pharmacists have been trained in vaccine delivery and this represents the majority of
the pharmacist workforce in the USA. There are examples of the beneficial impact of pharmacist involvement
as vaccine providers in community pharmacy settings.
Research limitations/implications – This review is based on a thorough review of the literature but was
not conducted in a systematic fashion.
Originality/value – This review provides a historical perspective and evidence of the benefit of pharmacists
as vaccine providers.
Keywords Health policy, Effectiveness, General practice, Health law or regulation, Infectious diseases,
Vaccines or vaccination
Paper type General review
Background
Vaccines represent one of the most significant advances in healthcare during the
twentieth century with progress continuing into the twenty-first century (Centers for
Disease Control and Prevention (CDC), 1999, 2011). The discovery and development of
vaccines began in the nineteenth century with smallpox vaccine, but did not gain
momentum until the middle of the twentieth century with the introduction of several
important vaccines, including the polio vaccine.
Vaccines represent a routine component in the care of infants, young children, and
adolescents. Vaccine schedules are available from the Centers for Disease Control and
Prevention (CDC) and proof of current vaccination status is often a requirement for
attendance in public schools (Centers for Disease Control and Prevention, 2017a;
SchoolVaxView, 2017). Vaccine schedules are also available for adult patients that detail
recommendations based upon age, medical conditions and risks (Centers for Disease Control
and Prevention, 2017b). Adherence to adolescent and adult immunization schedules is less
common, partly because there are fewer consequences related to access to community
resources and programs. An exception is that attendance at colleges and universities often
require proof of immunity against selected vaccine-preventable diseases. Another exception
is the requirement for multiple immunizations by members of the US military or the
requirement for those who work in healthcare settings to receive seasonal influenza vaccine.
Therefore, vaccination status for adults lags behind the Healthy People 2020 goals.
Annually, nearly 50,000 deaths in the USA are attributed to vaccine-preventable diseases
(US Department of Health and Human Services, 2017).
There are numerous reasons for failure to meet national standards for adult vaccination
coverage rates in the USA, including lack of time, access, awareness and resources.
One solution to address this problem gained momentum nearly 20 years ago when
the profession of pharmacy sought to include provision of vaccines in the scope of their
practice. As this unmet need for US adults was identified, public health officials also
recognized the potential of engaging pharmacists as an effective and accessible source for
vaccines (Rimer et al., 2014; Schuchat, 2015; National Vaccine Advisory Committee, 2016).
The administration of vaccines was also an opportunity for pharmacists to expand their
scope of practice and develop a financial model that was sustainable.
This review summarizes the history and successes of pharmacists as vaccine
providers, describes the training that pharmacists receive and the procedures that they
practice under to administer vaccines, details the impact of engaging pharmacists as
vaccine providers in the USA. Global involvement of pharmacists in vaccine delivery is
also briefly summarized.
History
Pharmacists have played an indirect role with vaccines for nearly 125 years, with the first
documented encounter of drugstores storing vaccines and preparing antitoxins for
administration in 1,895 (Grabenstein, 1999). During the early twentieth century, pharmacies
were a source of vaccine storage, preparation, and distribution. Later in the twentieth
century, pharmacists became more proactive as educators and advocates for vaccines. In the
1980s, pharmacy businesses began contracting with traveling nurse organizations to
conduct onsite influenza vaccination clinics (Hogue et al., 2006).
Activities began to advance quickly in the mid-1990s when the US Department of Health
and Human Services (DHHS) sought to enlist pharmacists as a resource to improve the
nation’s vaccination rates. The DHHS recognized the potential role of pharmacists in several
areas including vaccine education and awareness, distribution, access, administration, and
contributing to vaccine registries and systems.
Pharmacists first began administering immunizations in Washington State in response to
a change in the state pharmacy practice act. As a result, 50 pharmacists received training in
1994, and began administering vaccines to adults (Hogue et al., 2006). In 1996, the American
Pharmacists Association (APhA) responded to a request from the Mississippi Pharmacists
Association and the Mississippi Department of Public Health to engage pharmacists in
addressing disparities in vaccination rates for pneumococcal and influenza vaccine among
adults. This need resulted in the development of the national training program for
pharmacists in conjunction with the CDC (Hogue et al., 2006; Bach and Goad, 2015).
Over the next 20 years, increasing interest and changes in pharmacy practice acts have
resulted in a steady increase in pharmacists’ involvement as vaccine providers. Currently,
pharmacists in 52 states and territories in the USA are authorized to administer vaccines
(American Pharmacist Association, 2016). However, the privileges for pharmacists varies
among states based on the scope of practice defined in the state’s Pharmacy Practice Acts.
An impetus for promoting pharmacists as immunization providers was the historically low
rates of vaccinations among adults and disparities in selected populations, as well as the
access to pharmacist services based on extended hours of operation. Initial efforts of
pharmacists focused on adult vaccines, although a broader scope existed in some states.
Pharmacists are trusted professionals with the ability to promote awareness and importance
of vaccines. Factors supporting pharmacists as immunizers include access, convenience, and
consumer confidence and trust. It is estimated that over 90 percent of Americans live within
five miles of a community pharmacy (NACDS, 2010-2011). Approximately 275 million patient
visits are made to a pharmacy each week (Centers for Disease Control and Prevention, 2014).
In March 2014, the National Vaccine Advisory Committee (NVAC), which publishes
standards for immunization practice for all providers, included pharmacists in their
recommendations. The pharmacist’s role as vaccine providers has become a societal norm,
as pharmacies are now recognized as stakeholders in the initiative to increase vaccination
rates. However, there are still possible advantages in further expanding the scope of privileges
of pharmacists to cover additional vaccines and eligible patient populations.
Training
Other clinicians report safety and training as concerns for patients receiving vaccines in a
community pharmacy. The formal training and assessment that pharmacists are required to
complete are often more stringent than training of other practitioners. State Pharmacy Practice
Acts detail the required training for becoming an immunizing pharmacist, and the education
and training for continuing maintenance and competence. Themajority of pharmacists trained
as immunizers have completed a nationally developed certificate training program developed
by the APhA which is recognized by the CDC (Hogue et al., 2006). The program consists of a
12-hour home study, a live 8-hour session with practice applications, and a live skills
assessment in which the participant demonstrates competence in vaccine administration
technique. Other options are available for training but are similar in duration and scope to the
APhA program. As of 2017, over 300,000 US pharmacists have completed this program, which
represents the majority of the workforce (American Pharmacists Association, 2016).
Although not required by the Accreditation Council for Pharmacy Education, most
student pharmacists across the USA have completed the certificate training program in
immunization delivery as part of their required Doctor of Pharmacy curriculum. Qualified
student pharmacists can often provide vaccine services under the supervision of a
pharmacist with the credential, although this authority depends on the specific state of
practice. Upon graduation, newly licensed pharmacists are eligible to provide vaccine
services based on their credentialed training as a student and compliance with requirements
set by State Pharmacy Practice Acts.
Pharmacists and pharmacy settings also are required to adhere to identical federal
standards as other healthcare settings. Policies and procedures regarding regulations from
the Occupational Health and Safety Administration (OSHA) including bloodborne
pathogens practices, needlestick precautions, and the use of mandated safety devices are
mandatory, as are annual training and updates. Healthcare personnel at risk for exposures
are offered hepatitis B vaccine at no cost per OSHA. Pharmacists are also required to
maintain current provider-level basic life support certification and maintain emergency
management procedures. In reality, community pharmacies maintain safety standards and
processes that are equivalent to other settings. In addition, state pharmacy practice acts also
require annual continuing pharmacy education in the area of vaccines in order for
pharmacists to remain eligible as vaccine providers.
Another aspect of vaccine safety is related to errors made in selecting and administering
vaccine products to patients. With the growth in vaccines available and increasing
complexity of recommendations, this is an important issue. The Institute for
Safe Medication Practices established the Vaccine Error Reporting Program (VERP) in
2012 with a goal to reduce errors with ongoing learning and experiences. From September
2012 through October 2013, a total of 433 errors were submitted to VERP and 90 percent
resulted in a patient receiving a vaccine that they should not have. The most common
setting for errors was outpatient medical clinics (35 percent of reports). Physician offices
accounted for 29 percent of reports, and community pharmacies 2 percent (ISMP, 2013).
Similar to medical membership associations, leadership in pharmacy and the national
pharmacy organizations support and promote up to date vaccinations for pharmacists and
employees. Both the APhA and the American Society of Health System Pharmacists
maintain policies advocating for annual influenza vaccine among pharmacists. As it relates
to influenza vaccine, the goal for healthcare personnel according to the Healthy People 2020
initiative is 90 percent (US Department of Health and Human Services, 2017).
During the 2012-2013 season, the CDC began documenting influenza immunization rates
for pharmacist-administered vaccine. The reported rate has been 85.7 and 95.3 percent, for
2013-2014 and 2014-2015, respectively. This compares favorably with the overall rates for
healthcare personnel of 75.2 and 77.3 percent for the same time period (Black et al., 2015).
Scope of practice
Currently, 52 states and territories in the USA recognize pharmacists as a resource for
vaccinations. The pharmacist’s authority is governed by state pharmacy practice acts in a
manner similar to medical practice acts. Therefore, the scope of immunization services
varies among the states. This includes which vaccines can be administered, the age of
eligible patients, and the strategy for vaccine provision (standing orders, protocols or
individual prescription). An optimal approach involves pharmacists working
collaboratively with other healthcare professionals to improve outcomes for the patient.
This includes assessing and recommending appropriate vaccines, administering the
vaccine, and reporting administered vaccines to the primary care provider and/or the
immunization information system (IIS) (registry). In fact, the literature reports that
approximately 75 percent of general internists, family medicine physicians, and
pediatricians are willing to collaborate with community-based pharmacies as delivery
sites for adolescent and adult immunizations (Kempe et al., 2012; Hurley et al., 2011).
The initial engagement of pharmacists as vaccine providers was often restricted to
individuals ⩾18 years, and focused on influenza and pneumococcal vaccines. As of 2016,
28 states permit pharmacists to vaccinate patients of any age, 17 states permit vaccination
of patients between 3 and 17 years, and seven states permit vaccines for individuals
18 years of age or greater. For example, a recent change in California law allows
pharmacists to administer vaccines to individuals who are ⩾3 years of age; Texas law
allows for ⩾5 years of age; and in North Carolina, influenza vaccine can be administered to
patients ⩾14 years of age. Finally, the ability of student pharmacists to administer vaccines
under the supervision of a pharmacist credentialed as an immunizing pharmacist varies
depending on the state of practice (American Pharmacists Association, 2016).
Typical strategies for pharmacist authority to administer vaccines are through protocols,
standing orders, or by prescription. In many states, selected vaccines can be administered via
standing order or protocol and additional vaccines are allowable if prescribed by a physician.
Standing orders and protocols are similar approaches through which a physician approves
the procedures by which a pharmacist can offer and administer vaccines to eligible patients.
Standing orders and protocols are not patient, or physician, specific; thus, when in place,
the pharmacist can provide immunization services within the guidelines of the protocol
(Immunization Action Coalition, 2017; New York State Department of Health, 2012).
The components of a standing order or protocol are summarized in the list “Components of a
protocol for pharmacist vaccination services”. The final strategy for pharmacist authority is
through receipt of a prescription for the patient. This approach is the most restrictive because
it does not address improved access to vaccines as it still requires a prescriber intervention.
Components of a protocol for pharmacist vaccination services are as follows:
(1) states pharmacist(s) covered by the protocol;
(2) states sponsoring physician;
(3) indicates the vaccines that can be administered;
(4) describes processes and procedures, including decision-making process by
pharmacist to administer vaccine or refer patient;
(5) authorizes a plan for emergency management; and
(6) defines documentation and record-keeping procedures.
While barriers to pharmacist participation in vaccine services have lessened over time,
challenges still exist to developing and improving these activities. Practice acts and the
scope of services from a pharmacist are constantly changing based on unmet needs and
collaborations between pharmacists and other medical providers. Additionally, coverage
provided for pharmacist provision of vaccines by insurance companies remains a barrier.
One factor promoting pharmacists as vaccine providers in the USA is that many adult
vaccines are covered by Medicare Part D. Medicare Part D plans cover all commercially
available vaccines as long as the vaccine is reasonable and necessary to prevent illness
(e.g. herpes zoster or shingles vaccine) (Department of Health and Human Services, 2016).
Under this program, the coverage for the vaccine is part of the prescription drug benefit and
physician offices are often not able to bill for vaccine products under Medicare Part D. While
this facilitates the delivery of pharmacy-administered vaccine services, full coverage of
vaccine services by pharmacists is not provided consistently by insurance companies.
Pharmacists are required to adjudicate the claim in order to determine if the service is
covered or if the patient must pay out of pocket and file with the insurer directly. This may
hinder the patient’s ability to receive select vaccines, depending upon the patient’s financial
status and willingness to pay out of pocket at the time of vaccine administration.
Practice models and challenges
The effectiveness of pharmacists as immunizers is an important consideration in improving
vaccination rates. Pharmacists are viewed as knowledgeable health professionals and
trusted by the public. A randomized controlled trial in 1993 examined the effectiveness of
pharmacists in encouraging patients to receive vaccine from their medical provider
(Grabenstein et al., 1993). Participants who received advice from the pharmacist were
74 percent more likely to be vaccinated. A cost-effectiveness study suggested a savings to
Medicare of $280,000 based on reduced hospitalization (Grabenstein et al., 1992). Subsequent
studies over the next decade provided further evidence of the effectiveness of pharmacists in
influencing patients to receive vaccines (Hogue et al., 2006).
As pharmacists gained recognition as vaccine providers, pharmacies evolved from an
outsourced model for providing vaccines (e.g. traveling nurses) to incorporating
vaccine services into the regular workflow in the pharmacy. As the value of vaccine
services in community pharmacies grew, chain pharmacy organizations recognized
the potential and need for these services and embraced the concept of vaccines as a core
service in their pharmacy. This accelerated the growth and implementation as a service
that patients have come to expect from their community pharmacist. A common approach
is to incorporate the administration of vaccines into the normal dispensing activity of
practice, although this is often combined with targeted vaccine clinic days that can be
advertised and promoted. There are staffing considerations and workflow issues with
both approaches.
There has been a steady increase in the availability of immunization services during the
past two decades. In addition, the number of vaccine doses administered has increased with
the most consistent data available for influenza vaccines. Between 2007 and 2013, the number
of influenza vaccines administered in community pharmacy settings increased from 3.2 million
to 20.9 million (McConeghy and Wing, 2016). In 2016, 25 percent of all influenza vaccine doses
were administered by pharmacists (American Pharmacists Association, 2016).
Inserting vaccine services into the normal workflow in a community pharmacy setting
requires planning and preparation, including staff education. Pharmacy personnel,
including technicians and sales clerks, require training as to how to handle an immunization
request and what information to provide and obtain from the patient. The patient should be
informed about the expected wait time for a vaccine. In this scenario, the patient awaiting a
vaccine is normally placed in the cue along with patients awaiting their prescriptions.
When vaccine services are offered on an appointment basis, or during designated vaccine
clinic days, the pharmacy must plan for additional staffing in order to provide these services
(Watson and Bluml, 2013).
However, many community pharmacies are already busy with the traditional process of
medication dispensing, and implementing any new service can be challenging. In a 2009
report, factors influencing the sustainability of immunization services in community
pharmacists were evaluated (Westrick and Breland, 2009). Important factors that should be
considered during program development and implementation are given in the list “Factors
influencing sustainability of immunization service programs”. Additionally, the CDC
provides practice standards for all healthcare professionals to help ensure adult patients are
fully immunized. Steps include a vaccine status assessment, strongly recommending needed
vaccines, administration of (or referral for) vaccines, and documentation of vaccine receipt
(Centers for Disease Control and Prevention 2016a).
Factors influencing sustainability of immunization service programs are as follows:
(1) influential person in the organization serving as program champion;
(2) formal program evaluation for continuous improvement;
(3) willingness to modify program and services based on results;
(4) compatibility of service with organizational mission, resources, workflow, and
pharmacist’s skills; and
(5) comprehensive integration into the organizational structure.
A recent study evaluated the utility of a community pharmacy-based vaccine screening
program in determining patient eligibility for adult vaccines (Rhodes et al., 2017).
The program was conducted in a community pharmacy operating in five separate locations.
A vaccine screening tool and documentation form was utilized to collect information.
If appropriate, a pharmacist recommended vaccines for the patient who either accepted the
recommendation or provided a reason for declining. During this 30-day study, over
630 screenings were conducted primarily by technicians (95 percent) at the time of initial
presentation for data entry at the pharmacy (82 percent). These results demonstrate how
effective screening for vaccine needs can be incorporated into the workflow in a community
pharmacy setting.
Some pharmacies have employed mobile pharmacy vaccine clinics offered at business,
community, church or school locations have also demonstrated an impact. These events can
be efficient in that tens of thousands of vaccines have been administered at mobile clinics
and health fairs.
In a report to the US DHHS in 2013, the APhA reported on survey results from nearly
7,000 pharmacists conducted earlier in the year (American Pharmacists Association, 2016).
Over 75 percent of respondents were practicing in community pharmacy settings.
Approximately 86 percent of the practice sites offered vaccine services, and the majority
of practice sites (77 percent) offered immunizations to patients on a walk-in basis
(no appointment required). Appointment-based services had declined but were still available
in 36 percent of settings. The survey indicated an increase in referrals from physicians at
88 percent, while pharmacists referred an average of four patients per week back to the
primary care provider to address an immunization issue, and another 14 for other
medication-related issues. Over 90 percent of vaccines were administered to adult patients.
This report supported a steady trend toward increasing collaborations with other vaccine
providers to improve overall vaccination rates toward national goals.
Finally, a specialty area for vaccine services that some pharmacists have identified as an
unmet need is related to travel vaccines. Individuals traveling abroad on business, pleasure
or mission trips often require vaccinations in addition to other healthcare advice related to
their travel. These services are often not available in their local communities. Participation
in travel medicine, including vaccines, is not a standard part of State Pharmacy Practice
Acts but can be accommodated through expanded authority or collaborative practice
agreements in some states. Pharmacists can complete certification training in travel
medicine provided by the CDC, and APhA offers a training program for interested
individuals (American Pharmacists Association, 2016). The International Society of Travel
Medicine (2017) serves as additional resource that may be utilized by pharmacists who wish
to earn a certificate of knowledge in the practice of travel medicine.
In order to be effective in improving vaccination rates, pharmacists should develop and
maintain skills in counseling patients, including the use of motivational interviewing (MI)
strategies. The concept of MI was introduced approximately 30 years ago and involves
patient-centered communication and information exchange to facilitate constructive thought
among patients about their health (Emmons and Rollnick, 2001). MI is intended to result in
behavioral change and requires the clinician to express empathy, develop discrepancy in
thought, manage resistance, and support patient autonomy. Skill training in MI techniques is
recommended and evidence supports it effectiveness (Possidente et al., 2005). MI strategies
were assessed in the community pharmacy setting in a recent pilot study that concluded that
readiness to receive hepatitis B or pneumococcal vaccines was improved after receiving MI
(Brackett et al., 2015). MI strategies hold promise in improving immunization rates and these
skills should be encouraged for pharmacists.
Collaborations with public and private partners
Recognizing that adult vaccinations remain lower than national goals set forth by Healthy
People 2020, multiple initiatives are being considered within pharmacy practice to close the gap.
Healthcare organizations are realizing the unique role that community-based immunization
providers may play in reducing vaccine-preventable disease (US Department of Health and
Human Services, 2017; National Vaccine Advisory Committee (NVAC), 2012).
Pharmacists have taken a collaborative approach to providing immunization services by
partnering with advocates and immunization stakeholders. The goal of pharmacists as
vaccine providers has a stated purpose to improve the immunization status of the US Public.
A phrase that has been coined to reflect collaboration is the “Immunization Neighborhood.”
This approach has reached into the broader area of the pharmacist’s role is disaster relief
and pandemic preparedness (American Pharmacists Association, 2016). An example of
collaborative potential related to human papillomavirus (HPV) vaccination was published
by the CDC. In this model, the medical necessity for HPV vaccine was assessed and the first
dose would be administered by a medical provider. The patient would then be referred to a
community pharmacy setting where the subsequent doses could be administered, and the
pharmacist would provide documentation back to the medical provider (Centers for Disease
Control and Prevention (CDC), 2012).
The DHHS drafted a National Adult Immunization Plan (NAIP) to address ongoing
barriers and challenges to adult immunization. This guidance document outlines four goals
and 16 objectives that promote coordinated planning and action across US governmental
and non-governmental stakeholders to generate action through 2020. The four goals are to:
strengthen the adult immunization infrastructure, improve access to adult vaccines, increase
community demand for adult immunizations, and foster innovation in adult vaccine
development and vaccination-related technologies. Community immunizers are recognized
as part of the immunization neighborhood and are listed as non-governmental stakeholders
in the initiative to vaccinate. Upon review of the NAIP, a clear opportunity exists for
community-based immunizers to aid in the execution of each of the four goals and many of
the 16 objectives (US Department of Health and Human Services, 2015).
The Pharmacy Quality Alliance (PQA), a non-profit alliance with greater than 200 member
organizations, collaboratively promotes appropriate medication use and develops strategies
for measuring and reporting performance information related to medications. Measures
developed by the PQA are commonly used in the health insurance marketplace and by the
US Centers for Medicare and Medicaid Services. The PQA currently has 20 measures in effect,
and pharmacies are being assessed on their ability to perform each measure. Although the
measures are broadly distributed among medication use areas, there are three potential
immunization-related measures under consideration or in draft status by the PQA. These
measures include: immunization status assessment within medication therapy management,
Advisory Committee on Immunization Practices (ACIP) compliance following immunization
status assessment within medication therapy management, and ACIP schedule completion in
patients with diabetes. Pharmacists can expect to see these measures implemented in their
pharmacies in the upcoming months (Pharmacy Quality Alliance, 2017). As such, pharmacists
should begin to assess their current practices and envision how immunization status
assessment can be incorporated into day-to-day responsibilities.
In 2016, PQA released a white paper containing recommendations for improving adult
vaccination rates and reporting within community pharmacy practice. A key recommendation
set forward by the PQA was to identify immunization screening opportunities through
querying IIS, assessing immunization status by utilizing the pharmacy dispensing software,
leveraging an appointment-based model, and providing immunization screening during
medication therapy management services. The PQA also encouraged community pharmacies
to be advocates for immunization documenting and reporting to state or jurisdictional IIS,
electronic health records, and other pertinent healthcare providers.
The pharmacy profession has become an active participant in the NVAC (2012).
The NVAC proposes several standards for immunization providers. One standard relates to
consulting state-maintained vaccine registries and documenting vaccines administered.
IIS serve as a mechanism to document real time, consolidated immunization data and
services for healthcare providers in varying practice settings within a given state.
When state registries are available, pharmacists follow the same requirements as any
vaccine provider in using this resource (Centers for Disease Control and Prevention (CDC),
2016b). In fact, reporting requirements may be stricter for pharmacists than for other
healthcare providers. For example, pharmacists practicing in North Carolina are required to
document all immunizations other than influenza administered in the North Carolina IIS
within 72 hours of vaccine administration, while other healthcare providers in the state are
not held to the same standard (North Carolina General Statutes, 2015).
In September 2015, Assistant Surgeon General of the US Public Health Service, Anne
Schuchat, acknowledged the significant advances for pharmacists as vaccine providers, and
the contributions to improving overall immunization rates (Schuchat, 2015). In September of
2016, the director of the National Center for Immunization and Respiratory Diseases of the
CDC recognized the contributions and potential of pharmacists as vaccine providers in a
letter sent to the profession (Messonnier, 2016). She acknowledged that 280,000 pharmacists
had been trained as immunizers and that 25 percent of influenza doses as of November 2015
were administered in community pharmacy settings. She encouraged pharmacists to
continue these efforts with specific recommendations regarding the current seasonal
influenza season and acknowledged the importance of promoting other vaccines as well.
The director endorsed the concept of collaboration and the “immunization neighborhood.”
Impact of pharmacists as vaccine providers
Pharmacist participation in immunization programs has had a steady impact. In 2011,
an estimated 18 percent of all influenza vaccine doses were administered in community
pharmacy settings; by 2017, 25 percent of all influenza vaccines are administered in
pharmacy settings (Schwerzmann et al., 2017). Patients have identified convenience as a
factor for receiving their vaccinations in a pharmacy setting (Anderson and Thornley, 2014).
They can usually receive a vaccine without an appointment and without additional fees that
might accompany a medical visit.
A statewide survey of chain pharmacies conducted in California in 2007 reported that
vaccines were available in 500 pharmacies and from 1,000 pharmacist-immunizers
(Pilisuk et al., 2010). These services were available on an expanded basis including evening
and weekend hours, and provided on a walk-in basis. Influenza and pneumococcal vaccines
were the most often administered vaccines. There was evidence of expansion beginning
toward other vaccines and the respondents expressed interest in resources to keep up to
date, and in collaborations with other vaccine partners.
A 2015 systematic review included 36 studies that assessed the impact of pharmacists on
vaccine administration rates. Pooled analysis of the six randomized, controlled trials
demonstrated significant increases in vaccination rates when pharmacists participated
as educators, facilitators, or vaccine providers with an overall risk ratio (RR) of 2.74
(95% CI 1.58, 4.74) (Isenor et al., 2016a). Another systematic review concluded that although
evidence exists that supports the fact that providing vaccines in community pharmacies
would increase overall vaccination rates, there are legal, organizational and attitudinal
barriers that should be addressed (Burson et al., 2016).
The capacity of pharmacists to improve rates of seasonal influenza vaccination during a
pandemic was estimated in a model simulation study in which possible rates were evaluated
with or without retail pharmacy involvement. The investigators reported that retail
pharmacist participation increased vaccination capacity to 25 million doses weekly during a
pandemic, and that the time to achieve 80 percent coverage nationally was reduced by seven
weeks (Schwerzmann et al., 2017). The authors concluded that pharmacists should be
integrated into pandemic vaccine response planning efforts. Another evaluation assessed
the status of collaboration between public health and community pharmacies in pandemic
planning in 2014 as reported to the CDC. According to the results, 88.7 percent of public
health programs included pharmacies in pandemic vaccine distribution plans, 45.3 percent
maintained processes to recruit pharmacists as vaccine providers, and 30.8 percent had
formal, established relationships with pharmacies (Fitzgerald et al., 2016). These authors
concluded that further efforts were warranted to fully engage pharmacists in preparation
for a pandemic event.
The concept of promoting the “immunization neighborhood” has been suggested as a
strategy for improving HPV vaccination rates. Collaborations between physicians and
pharmacists should improve education and awareness about the benefits of HPV vaccine,
and improve the rates of completion of the vaccine series where initial doses may be
received in a medical office and subsequent doses in a community pharmacy (Rothholz and
Tan, 2016). A national survey (n¼ 1,255) conducted in 2014 reported that 29 percent of
parents were willing for their adolescent children to receive the HPV vaccine in a pharmacy.
The survey assessed parents’ perceptions of pharmacist vaccination skills with seven items;
responses to these items (on a five-point Likert scale) were averaged to create a scale of
perceived pharmacist vaccination skills. Willingness was higher among parents who
thought pharmacists were skilled at vaccine administration (OR¼ 2.05, 95% CI 1.07, 2.52,
where OR is the change in odds of parental willingness to get HPV vaccine at a pharmacy
for every one-unit increase in scale score) (Calo et al., 2017). Also of interest, willingness of
parents to have their children vaccinated by a pharmacists varied depending on the specific
vaccine with influenza at 62 percent and tetanus-toxoid, diphtheria-toxoid, acellular
pertussis vaccine (Tdap) at 41 percent.
A multimodal strategy for a pharmacist-lead intervention was evaluated in an independent
community pharmacy setting in Tennessee during an eight week pilot study in 2015.
An educational intervention designed to raise awareness about HPV vaccination was directed
to a targeted population in the pharmacy, nearby physician offices, and the general public in
the community. A subsequent survey (n¼ 21) in the pharmacy reported that ten patients had
received one or more doses of HPV vaccine during the study period with the pharmacist
recommendation being the most common education methods for awareness of the vaccine
(n¼ 10), as well as the reason for being vaccinated (n¼ 6). Commonly cited reasons for not
being vaccinated were costs and lack of insurance coverage (Hohmeier et al., 2016).
A six-month pilot study conducted in three independent community pharmacies in
Tennessee significantly increased the number of zoster vaccines administered from 59 to 193
(immunization rate increase from 0.37 to 1.20 percent, po0.0001) through local marketing
strategies and advocacy during prescription refills (Wang et al., 2013). As described earlier,
Rhodes and colleagues demonstrated that a vaccine screening program was successfully
incorporated into a community pharmacy practice and relied largely on pharmacy technicians
for implementation (Rhodes et al., 2017).
A study at a large chain pharmacy was conducted over a 16 month period to improve
pneumococcal vaccination rates among high risk patients (Taitel et al., 2011). When patients
(n¼ 2,095,748) were receiving influenza vaccine at a pharmacy in the system, they were
screened by the pharmacist to determine if they were at high risk for pneumococcal disease
as well and were offered pneumococcal polysaccharide 23-valent vaccine (PPSV23) if they
qualified (n¼ 1,343,751). Among eligible patients, 4.9 percent received the pneumococcal
polysaccharide vaccine (PPSV23) which was significantly higher than the benchmark
reported for traditional care (2.9 percent).
Another study at a chain pharmacy located on the campus of a women’s hospital was a
two-year effort to improve vaccination with Tdap for individuals in close contact with
newborns (Mills et al., 2014). Information about the importance of receiving the vaccine was
shared with delivering families and a pharmacist held a vaccination clinic for two hours
each day. The average monthly rate of Tdap vaccine administered during the study period
was more than ten times higher than the rate at comparable pharmacies in the area
(83.9 vaccines/month vs 2.7 vaccines/month, po0.01). The investigators reported that
collaboration among all parties involved was a key to successful implementation of
the program.
The potential impact of vaccine services in community pharmacies to improve
vaccination rates for underserved populations has been highlighted (Murphy et al., 2012).
This retrospective analysis examined influenza vaccines administered in a major
chain pharmacy located in areas designated as medically underserved (which constitutes
43 percent of the US population). Of the 4.5 million doses of influenza vaccine administered
by the chain during the 2009-2010 influenza season, nearly 38 percent were administered
to patients in medically underserved areas. The authors highlighted the potential impact
for over 130 million Americans, and the convenience and access for receiving vaccines in
community pharmacy settings.
In a meta-analysis of pharmacist-administered vaccine programs, investigators included
eight studies and found that the overall RR for receiving a vaccine with pharmacist
participation compared to a non-pharmacist-based approach was 2.95 ( po0.001), and it
varied among the specific vaccine administered. The relative risk was lowest for influenza
(2.23) and highest for zoster vaccine (4.78) (Baroy et al., 2016). These data support the
position that pharmacist-based immunization programs containing an advocacy component
can significantly improve vaccine rates among adults, which will likely be needed to achieve
national goals and initiatives for adult vaccination.
Global activities of pharmacists in vaccine education, advocacy, and delivery
Although this review has focused on the evolution and implementation of vaccine services
in the USA, there are numerous examples of the state of pharmacy practice in other
countries. For example, pharmacist involvement in England and Canada has been
substantial. Nonetheless, there are numerous countries where pharmacist involvement as
vaccine providers has not been considered.
Pharmacist involvement in administering vaccines varies globally. Authority is granted to
various extents in some developed countries, including Canada, Ireland, New Zealand, Portugal,
and the UK. New authority is also emerging in parts of Australia (Hattingh et al., 2016).
However, the potential benefits of including pharmacists as vaccine providers is largely
unrealized globally (Isenor et al., 2016b).
In May 2012, the Ministers of Health from 194 countries convened at the World Health
Assembly and endorsed a Global Vaccine Action Plan (GVAP, 2012). The action plan
serves as a roadmap to “improve health by extending the full benefits of immunization to
all people, regardless of where they are born, who they are, or where they live” by 2020
and beyond. The GVAP employs six guiding principles: country ownership, shared
responsibility and partnership, equity, integration, sustainability, and innovation.
There exists six strategic objectives and measurement indicators as well as recommended
action steps action steps to ensure the achievement of the goals. It is hoped that the
profession of pharmacy can be engaged with the GVAP in similar ways that US
pharmacists have collaborated with the NVAC. A partnership would help the GVAP meet
worldwide objectives.
The possible benefit of enlisting community pharmacists to provide influenza vaccine
was evaluated in Canada. The investigators cited the historically low rate of influenza
vaccination among its citizens, as well as patient interest and pharmacist willingness to
provide this service. During the period of 2007-2014, the reported rate for influenza
vaccination was 28.8 percent which would be increased by 2.2 percent if policy changes
provided for pharmacist to provide the vaccine. The authors suggested that this
modest increase may be beneficial if it improved awareness of overall strategies to reduce
the risk of influenza infection. They also noted that 80 percent of citizens receive
non-vaccine services from a pharmacist annually and could receive vaccine reminders
(Buchan et al., 2017).
Attitudes among the public and other healthcare professionals about pharmacists as
vaccine providers in Canada reflect several of the same results reported in the USA.
A national survey from 2015 reported that 64.6 percent of the public, 57.4 percent of nurses,
and 38.9 percent of physicians supported pharmacists as vaccine providers, with
45.7 percent of physicians opposing this position. Common concerns that were expressed
included safety and reporting and sharing of vaccination status among healthcare
providers. Concerns were more common in areas of the country where pharmacists were not
yet acting as vaccine providers (MacDougall et al., 2016).
A study from Nova Scotia evaluated influenza vaccination coverage rates as a result of
adding pharmacists as vaccine providers in 2013. Vaccination rates for all residents were
reported as 41.8 and 39.9 percent during the first two years, compared to 35.8 percent in the
year prior to pharmacist authority. For patients at least 65 years of age in the community,
the rates were 71.6 and 73.3 percent compared to historical rates of 61.8 percent prior to
pharmacist participation (Isenor, 2016b).
A comprehensive literature review from the UK in 2010 focused on vaccination services
in community pharmacies (Francis and Hinchliffe, 2010). At the time of the report, vaccine
services in community pharmacy settings were widely available and focused primarily on
influenza and travel vaccines, although other vaccines were offered. The convenience and
access to community pharmacists was viewed as a benefit and the potential to improve
national immunization rates was acknowledged although research in this area was limited.
The impact of a community pharmacist initiative to provide seasonal influenza vaccine
in London was assessed during 2011 and 2015. The reporting for vaccines received in
pharmacies (2013-2015) was separate from the reports received from general practitioners in
London (2011-2015). Influenza vaccination rates ranged from 59.7 to 60.4 percent during the
study period and did not reflect any differences. The investigators reported that the cost to
the National Health Service was lower when patients received influenza vaccine in a
community pharmacy but that separate reporting systems was problematic and should be
addressed (Atkins et al., 2016).
In the second year of a newly initiated program in community pharmacies in Western
Australia, over 15,000 influenza vaccines were administered at 76 community pharmacies
between March and October of 2015. There were no reports of serious adverse reactions.
Pharmacists expressed confidence in their abilities as vaccine providers and patients were
satisfied with the access and convenience of the services. Many of the vaccines were
administered in rural and remote areas of the country (Hattingh et al., 2016).
Conclusion
Pharmacists have been involved with vaccine storage and handling for more than a century.
During the 1990s, interest in engaging pharmacists as vaccine providers occurred within
and outside of the profession. The involvement of pharmacists in administering vaccines is
now common in the USA and there are examples of an increasing role globally.
The evidence regarding the impact of pharmacists in improving vaccination rates is
inconsistent, but substantial needs and opportunities are available for collaboration with
other health professionals to improve the health of the public through vaccination.
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